Cancer

News

Bayer takes control of Loxo duo as Lilly closes takeover

Bayer has acquired full rights to two drugs partnered with Loxo Oncology, on the same day that the biotech was taken over by Eli Lilly in an

News

Bayer/Orion showcase results from prostate cancer challenger

Bayer and development partner Orion have released detailed results from the trial that will form the backbone of its filing for their latest prostate cancer drug, as they aim to take on two

News

Merck's Keytruda gets boost in kidney and head and neck canc...

Merck & Co and its cancer immunotherapy Keytruda has gained a double boost in its tussle with rival Bristol-Myers Squibb, with positive results in kidney cancer, and the promise of an F

News

Grey Wolf raises £10m for tumour 'illumination' tech

Immuno-oncology biotech Grey Wolf Therapeutics has raised £10 million in series A financing to develop therapies that increase tumour visibility.

News

GSK bolts-on immuno-oncology candidate with €3.7bn Merck dea...

GlaxoSmithKline is making another big play in cancer, signing a wide-ranging deal with Merck KGaA for M7824, an immuno-oncology drug that made a splash at last year’s ESMO meeting.

Views & Analysis

Oncology round-up: CAR-T conference raises hopes for solid t...

Kisaco Research’s CAR-T Congress EU could not have come at a better time – the day after it finished NICE announced it had granted funding for a new use for Novartis’ cancer cell therapy Ky

Bayer takes control of Loxo duo as Lilly closes takeover

Bayer/Orion showcase results from prostate cancer challenger

Merck's Keytruda gets boost in kidney and head and neck canc...

Grey Wolf raises £10m for tumour 'illumination' tech

GSK bolts-on immuno-oncology candidate with €3.7bn Merck dea...

Oncology round-up: CAR-T conference raises hopes for solid t...

Delivering the right behavioural ingredients for the moment,...

How to meet your physicians where they are online

Cancer

Editor's Picks